Смешанное тревожное и депрессивноерасстройство в общей медицинской практике
Смешанное тревожное и депрессивноерасстройство в общей медицинской практике
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Kessler RS, Wittchen HU. Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 2002; 63(suppl. 8): 4–10.
2. Михайлова Н.М., Сиряченко Т.М. Тревожное расстройство в позднем возрасте. Рус. мед. журн. 2006; 14(29).
3. Старостина Е.Г. Генерализованное тревожное расстройство и симптомы тревоги в общемедицинской практике. Кардиоваск. тер. и проф. 2006; 3: 111–20.
4. Harter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and medical illness. Eur Arch Psychiatry Clin Neurosci 2003; 253: 313–20.
5. Leppavuori A, Kaste M, Erkinjuntti T. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol 2001; 8(4): 315–9.
6. Wittchen H-U, Jakobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–76.
7. Ballenger JC, Davidson JRT, Lecrubier Y et al. Consensus statement on generalized anxiety disorder from the International Consensus group on Depression and anxiety. J Clin Psychiatry 2001; 62(suppl. 11): 53–8.
8. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: МИА, 2003: 163–9.
9. Stocchi F, Nordera G, Jokinen R et al. Efficacy and tolerability of paroxetine for the long–term treatment of generalized anxiety disorder. J Clin Psychiatry 2003; 64: 250–8.
10. Sansone RA, Hendricks CM, Sellbom M, Reddington A. Anxiety symptoms and healthcare utilization among a sample of outpatients in an internal medicine clinic. Int J Psychiatry Med. 2003; 33(2): 133–9.
11. Farnworth NB et al. Treatment with Herbal Medicines. WHO Bull. 1985; 63.
12. Вознесенская Т.Г. Эмоциональный стресс и профилактика его последствий. Рус. мед. журн. 2006; 14(9).
13. Ortiz JG, Nieves–Natal J, Chavez P. Effects of Valeriana officinalis extracts on [3H] flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. J Neurochem Res 1999; 24: 1373–8.
14. Schumacher B, Scholle S, Holzl J et al. Lignans isolated from valerian: identification and characterization of a new olivi derivative with partial agonistic activity at A1 adenosine receptors. J Nat Prod 2002; 65: 1479–85.
2. Михайлова Н.М., Сиряченко Т.М. Тревожное расстройство в позднем возрасте. Рус. мед. журн. 2006; 14(29).
3. Старостина Е.Г. Генерализованное тревожное расстройство и симптомы тревоги в общемедицинской практике. Кардиоваск. тер. и проф. 2006; 3: 111–20.
4. Harter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and medical illness. Eur Arch Psychiatry Clin Neurosci 2003; 253: 313–20.
5. Leppavuori A, Kaste M, Erkinjuntti T. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol 2001; 8(4): 315–9.
6. Wittchen H-U, Jakobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–76.
7. Ballenger JC, Davidson JRT, Lecrubier Y et al. Consensus statement on generalized anxiety disorder from the International Consensus group on Depression and anxiety. J Clin Psychiatry 2001; 62(suppl. 11): 53–8.
8. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: МИА, 2003: 163–9.
9. Stocchi F, Nordera G, Jokinen R et al. Efficacy and tolerability of paroxetine for the long–term treatment of generalized anxiety disorder. J Clin Psychiatry 2003; 64: 250–8.
10. Sansone RA, Hendricks CM, Sellbom M, Reddington A. Anxiety symptoms and healthcare utilization among a sample of outpatients in an internal medicine clinic. Int J Psychiatry Med. 2003; 33(2): 133–9.
11. Farnworth NB et al. Treatment with Herbal Medicines. WHO Bull. 1985; 63.
12. Вознесенская Т.Г. Эмоциональный стресс и профилактика его последствий. Рус. мед. журн. 2006; 14(9).
13. Ortiz JG, Nieves–Natal J, Chavez P. Effects of Valeriana officinalis extracts on [3H] flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. J Neurochem Res 1999; 24: 1373–8.
14. Schumacher B, Scholle S, Holzl J et al. Lignans isolated from valerian: identification and characterization of a new olivi derivative with partial agonistic activity at A1 adenosine receptors. J Nat Prod 2002; 65: 1479–85.
Авторы
Э.Ю.Соловьева
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.